- Easy Tracking In The Watchlist
Is Traws Pharma, Inc. stock still a buy after falling -9.88% on Monday?
(Updated on Jul 13, 2026)
The Traws Pharma, Inc. stock price fell by -9.88% on the last day (Monday, 13th Jul 2026) from $0.760 to $0.685. During the last trading day the stock fluctuated 8.47% from a day low at $0.667 to a day high of $0.723. The price has fallen in 6 of the last 10 days and is down by -17.18% for this period. Volume has increased on the last day by 17 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 141 thousand shares were bought and sold for approximately $96.32 thousand.
The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.621 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -34.40% during the next 3 months and, with a 90% probability hold a price between $0.407 and $1.04 at the end of this 3-month period.
TRAW Signals & Forecast
A buy signal was issued from a pivot bottom point on Wednesday, July 08, 2026, and so far it has risen 3.47%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Traws Pharma, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.718 and $1.08. A break-up above any of these levels will issue buy signals. Traws Pharma, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Traws Pharma, Inc. stock
Traws Pharma, Inc. finds support from accumulated volume at $0.675 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0565 between high and low, or 8.47%. For the last week, the stock has had daily average volatility of 10.96%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (TRAW) For The Upcoming Trading Day Of Tuesday 14th
For the upcoming trading day on Tuesday, 14th we expect Traws Pharma, Inc. to open at $0.692, and during the day (based on 14 day Average True Range), to move between $0.632 and $0.738, which gives a possible trading interval of +/-$0.106 (+/-16.81%) up or down from last closing price. If Traws Pharma, Inc. takes out the full calculated possible swing range there will be an estimated 16.81% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $0.675 (1.43%) than the resistance at $0.756 (10.35%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Traws Pharma, Inc. stock A Buy?
Traws Pharma, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score:
-3.525
Sell Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on July 14, 2026 - $0.692 ( 0.98%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
TRAW Performance
Trading levels for TRAW
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.748 | 9.23% |
| R2 | 0.727 | 6.08% |
| R1 | 0.713 | 4.13% |
| Price | 0.685 | |
| S1 | 0.670 | -2.17% |
| S2 | 0.657 | -4.12% |
| S3 | 0.635 | -7.27% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.85 | 24.15% |
| R2 | 0.84 | 22.03% |
| R1 | 0.756 | 10.35% |
| Price | 0.685 | |
| S1 | 0.675 | -1.43% |
| S2 | 0.662 | -3.36% |
| S3 | 0 | - |
FAQ
Click here for our free guide on how to buy Traws Pharma, Inc. Stock.
Buy TRAW